The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome
Open Access
- 31 March 2009
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 94 (5), 729-732
- https://doi.org/10.3324/haematol.2008.002063
Abstract
We studied the impact of comorbidities on survival and evaluated the prognostic utility of comorbidity scores in MDS patients, who received best supportive care and were assessable according to the Charlson Comorbidity Index (CCI) and the Hematopoietic Stem Cell Transplantation Comorbidity Index (HCTCI): 171 patients were identified in the Duesseldorf MDS Registry. The HCTCI captured more comorbidities. Both scoring systems had prognostic relevance, but the HCTCI more clearly distinguished between low-, intermediate- and high-risk patients. Median survival times of the different risk groups according to the HCTCI were 68, 34 and 25 months, respectively. The HCTCI showed prognostic impact in the IPSS intermediate- and high-risk group. On multivariate regression analysis, only the HCTCI remained a prognostic factor independent of IPSS. Considering their prognostic impact, comorbidities of MDS patients should receive appropriate attention in clinical trials as well as day-to-day clinical decision making.This publication has 11 references indexed in Scilit:
- Comorbidity and Disease Status–Based Risk Stratification of Outcomes Among Patients With Acute Myeloid Leukemia or Myelodysplasia Receiving Allogeneic Hematopoietic Cell TransplantationJournal of Clinical Oncology, 2007
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood, 2005
- Korreliert der Charlson-Comorbidity-Index mit dem postoperativen Verlauf bei Patienten mit Magenkarzinom?Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie, 2003
- Measurement and impact of comorbidity in older cancer patientsCritical Reviews in Oncology/Hematology, 2000
- The Impact of Comorbidity and Age on Survival with Laryngeal CancerEar, Nose & Throat Journal, 1999
- Validation of the Charlson Comorbidity Index in Patients With Head and Neck Cancer: A Multi‐institutional StudyThe Laryngoscope, 1997
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994
- Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.1992
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- The pre-therapeutic classification of co-morbidity in chronic diseaseJournal of Chronic Diseases, 1970